High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression.
We have undertaken a genome-wide single nucleotide polymorphism (SNP) array analysis of 41 chronic myeloid leukemia (CML) patients. In total, 44 regions of uniparental disomy (UPD) >3 Mb were identified in 24 of 32 patients in chronic phase (CP), and 21 regions of UPD >3 Mb were identi...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2010
|
_version_ | 1826264124843098112 |
---|---|
author | Boultwood, J Perry, J Zaman, R Fernandez-Santamaria, C Littlewood, T Kusec, R Pellagatti, A Wang, L Clark, R Wainscoat, J |
author_facet | Boultwood, J Perry, J Zaman, R Fernandez-Santamaria, C Littlewood, T Kusec, R Pellagatti, A Wang, L Clark, R Wainscoat, J |
author_sort | Boultwood, J |
collection | OXFORD |
description | We have undertaken a genome-wide single nucleotide polymorphism (SNP) array analysis of 41 chronic myeloid leukemia (CML) patients. In total, 44 regions of uniparental disomy (UPD) >3 Mb were identified in 24 of 32 patients in chronic phase (CP), and 21 regions of UPD >3 Mb were identified in 13 of 21 patients in blast crisis (BC). Chromosome 8 had the highest frequency of UPD regions in both CP and BC samples. Eight recurrent regions of UPD were observed among the 41 patients, with chromosome 8 showing the highest frequency. Ten regions of copy number change (CNC) >3 Mb were observed in 4 of 21 patients in BC, whereas none were observed in CP. We have identified several recurrent regions of UPD and CNC in CML that may be of pathogenetic importance. Overrepresentation of genomic aberrations (UPD and copy number gain) mapping to chromosome 8 was observed. Selected candidate genes mapping within the aberrant genomic regions were sequenced and mutation of the TP53 gene was observed in one case in BC and of the ASXL1 gene in 6 of 41 cases in CP or BC. Mutation of ASXL1 represents an important new molecular abnormality in CML. |
first_indexed | 2024-03-06T20:02:44Z |
format | Journal article |
id | oxford-uuid:27e11cef-6f9a-43d4-b227-8eff532b7445 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-06T20:02:44Z |
publishDate | 2010 |
record_format | dspace |
spelling | oxford-uuid:27e11cef-6f9a-43d4-b227-8eff532b74452022-03-26T12:09:32ZHigh-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:27e11cef-6f9a-43d4-b227-8eff532b7445EnglishSymplectic Elements at Oxford2010Boultwood, JPerry, JZaman, RFernandez-Santamaria, CLittlewood, TKusec, RPellagatti, AWang, LClark, RWainscoat, JWe have undertaken a genome-wide single nucleotide polymorphism (SNP) array analysis of 41 chronic myeloid leukemia (CML) patients. In total, 44 regions of uniparental disomy (UPD) >3 Mb were identified in 24 of 32 patients in chronic phase (CP), and 21 regions of UPD >3 Mb were identified in 13 of 21 patients in blast crisis (BC). Chromosome 8 had the highest frequency of UPD regions in both CP and BC samples. Eight recurrent regions of UPD were observed among the 41 patients, with chromosome 8 showing the highest frequency. Ten regions of copy number change (CNC) >3 Mb were observed in 4 of 21 patients in BC, whereas none were observed in CP. We have identified several recurrent regions of UPD and CNC in CML that may be of pathogenetic importance. Overrepresentation of genomic aberrations (UPD and copy number gain) mapping to chromosome 8 was observed. Selected candidate genes mapping within the aberrant genomic regions were sequenced and mutation of the TP53 gene was observed in one case in BC and of the ASXL1 gene in 6 of 41 cases in CP or BC. Mutation of ASXL1 represents an important new molecular abnormality in CML. |
spellingShingle | Boultwood, J Perry, J Zaman, R Fernandez-Santamaria, C Littlewood, T Kusec, R Pellagatti, A Wang, L Clark, R Wainscoat, J High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression. |
title | High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression. |
title_full | High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression. |
title_fullStr | High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression. |
title_full_unstemmed | High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression. |
title_short | High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression. |
title_sort | high density single nucleotide polymorphism array analysis and asxl1 gene mutation screening in chronic myeloid leukemia during disease progression |
work_keys_str_mv | AT boultwoodj highdensitysinglenucleotidepolymorphismarrayanalysisandasxl1genemutationscreeninginchronicmyeloidleukemiaduringdiseaseprogression AT perryj highdensitysinglenucleotidepolymorphismarrayanalysisandasxl1genemutationscreeninginchronicmyeloidleukemiaduringdiseaseprogression AT zamanr highdensitysinglenucleotidepolymorphismarrayanalysisandasxl1genemutationscreeninginchronicmyeloidleukemiaduringdiseaseprogression AT fernandezsantamariac highdensitysinglenucleotidepolymorphismarrayanalysisandasxl1genemutationscreeninginchronicmyeloidleukemiaduringdiseaseprogression AT littlewoodt highdensitysinglenucleotidepolymorphismarrayanalysisandasxl1genemutationscreeninginchronicmyeloidleukemiaduringdiseaseprogression AT kusecr highdensitysinglenucleotidepolymorphismarrayanalysisandasxl1genemutationscreeninginchronicmyeloidleukemiaduringdiseaseprogression AT pellagattia highdensitysinglenucleotidepolymorphismarrayanalysisandasxl1genemutationscreeninginchronicmyeloidleukemiaduringdiseaseprogression AT wangl highdensitysinglenucleotidepolymorphismarrayanalysisandasxl1genemutationscreeninginchronicmyeloidleukemiaduringdiseaseprogression AT clarkr highdensitysinglenucleotidepolymorphismarrayanalysisandasxl1genemutationscreeninginchronicmyeloidleukemiaduringdiseaseprogression AT wainscoatj highdensitysinglenucleotidepolymorphismarrayanalysisandasxl1genemutationscreeninginchronicmyeloidleukemiaduringdiseaseprogression |